[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market

[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market

12 Minuten

Beschreibung

vor 2 Jahren

Multinational pharmaceutical firms are changing strategies and
selling business lines, as a government bulk-buying program
favors cheaper, local products.


Click here to read the article by Tang Hanyu and Kelly
Wang.


Narrated by Elyse Ribbons.


See Privacy Policy at https://art19.com/privacy and California
Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15